Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | ELEV | Series A Preferred Stock | Jun 24, 2021 | Common Stock | 1.66M | Direct | F1, F2 | |||||||
holding | ELEV | Series B Preferred Stock | Jun 24, 2021 | Common Stock | 401K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | The shares of the Issuer's Preferred Stock will automatically convert on a 4.225582-for-one basis into the number of shares of the issuer's Common Stock shown in column 3 immediately upon the closing of the issuer's initial public offering, and has no expiration date. |
F2 | The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. ("Qiming"). Qiming U.S. Healthcare GP II, LLC ("Qiming GP") is the General Partner of Qiming, and may deem beneficial ownership of shares held by Qiming, and includes Gary Rieschel, as Managing Member of Qiming GP, and Mark McDade, Co-Founder, and Partner of Qiming, that each may share voting and investment power of the shares held by Qiming. |